MSLN and ovarian carcinoma: Studies on ovarian cancer have found that the specific binding of MSLN and carbohydrate antigen 125 (CA125) can mediate and enhance the adhesion of tumor cells, which promotes the extensive implantation and metastasis of ovarian cancer in the pelvic and abdominal cavity (13, 15).